In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Meet the 2013 EAPCI Grant Winners

Jean Fajadet and Stephan Windecker, on behalf of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), awarded the five winners from Italy, Spain, Belgium and Poland supported by an unrestricted educational grant

Every year, the EAPCI gives fellowship awards for young practitioners from European countries interested in broadening their clinical and research skills through a one-year maximum experience in cardiology practices outside their own country. The goal is to enable them to contribute to the enhancement of their country’s academic standards upon return and to encourage exchanges and interactions between countries.



At the closing of the ceremony, J. Fajadet said: “I would like to thank all the industries that supported these awards. It is very important for our community to support the young investigators and it is important for them to spend a year in high level centres in Europe. Every year of this award there is a call for fellowship and this is around January. I invite all the young fellows to send the applications. They need to be approved by the official committee of EAPCI well in advance.

The winners of this year’s awards are as follows (from left to right):



Stylianos Pyxaras

  • From: Belgium
  • Going to: Germany
  • Host centre: Gemeinschaftskrankenhaus Bonn, St Petrus (Bonn)
  • Supervisor: Ulrich Gerckens
  • Grant: Training
  • Topic: Role of von Willebrand factor and ADAMTS-13 in patients with aortic stenosis undergoing TAVI
  • Sponsor: Thanks to an unrestricted educational grant from Medtronic

Ramon Rodriguez

  • From: Spain
  • Going to: The Netherlands
  • Host centre: Erasmus Medical Center (Rotterdam)
  • Supervisor: Peter de Jaegere
  • Grant: Training
  • Topic: Paravalvular aortic regurgitation after TAVI with the Edwards Sapien and Corevalve Revalving system devices. The role of aortic root calcification
  • Sponsor: Thanks to an unrestricted educational grant from Edwards Lifesciences

Elena Guerra

  • From: Italy
  • Going to: Germany
  • Host centre: Deutsches Herzzentrum München (Munich)
  • Supervisor: Adnan Kastrati
  • Grant: Research
  • Topic: Intracoronary stenting and angiographic results: Orsiro vs Xience Prime stents assessed by optical coherence tomography (ISARORSIRO OCT)
  • Randomised trial of sirolimus eluting stents vs. everolimus eluting stents regarding stent coverage assessed by optical coherence tomography
  • Sponsor: Thanks to an unrestricted educational grant from Biosensors 

Ernest Spitzer

  • From: Spain
  • Going to: Switzerland
  • Host centre: Bern University Hospital (Bern)
  • Supervisor: Stephan Windecker
  • Grant: Research
  • Topic: Bioresorbable everolimus-eluting coronary scaffolds for the treatment of in-stent restenosis: 9-month OCT results; the BESTest study
  • Sponsor: Thanks to an unrestricted educational grant from Terumo Europe

Milosz Jaguszewski (not present)

  • From: Poland
  • Going to: Switzerland
  • Host centre: University Heart Center (Zurich)
  • Grant: Training
  • Topic: Effects of a drug-eluting stent compared to a bare-metal stent in patients with a cardiogenic shock (with or without ST-segment elevation myocardial infarction) undergoing primary PCI - A randomized, single-blinded, controlled multicenter trial
  • Sponsor: Thanks to an unrestricted educational grant from Medtronic

This programme is supported by an unrestricted educational grant from Biosensors International, Edwards Lifesciences, Medtronic and Terumo Europe.